The need for development of other enterovirus vaccines in addition to EV-A71 vaccine

The need for development of other enterovirus vaccines in addition to EV-A71 vaccine

Bibliographic Details
Main Authors:	Daoyan Xu, Jian Li
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	Human Vaccines & Immunotherapeutics
Online Access:	https://www.tandfonline.com/doi/10.1080/21645515.2024.2340854

Similar Items

EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases
by: Qunying Mao, et al.
Published: (2016-01-01)

Development and characterization of an enterovirus 71 (EV71) virus-like particles (VLPs) vaccine produced in Pichia pastoris
by: Zhijian Yang, et al.
Published: (2020-07-01)

Enterovirus A71 Vaccines
by: Mei-Ling Li, et al.
Published: (2021-02-01)

EV71 vaccination impact on the incidence of encephalitis in patients with hand, foot and mouth disease
by: Jian Li, et al.
Published: (2021-07-01)

Development of a Deoxyribonucleic Acid Vaccine Against Enterovirus 71
by: Wong, Siew Tung
Published: (2005)

Five-year immunity persistence following immunization with inactivated enterovirus 71 type (EV71) vaccine in healthy children: A further observation
by: Yuemei Hu, et al.
Published: (2018-06-01)

EV71 vaccines: a milestone in the history of global vaccine development
by: Shan Lu
Published: (2014-01-01)

Inhibition of Enterovirus 71 (EV-71) Infections by a Novel Antiviral Peptide Derived from EV-71 Capsid Protein VP1
by: Tan, C.W., et al.
Published: (2012)

Functional Insights into Silymarin as an Antiviral Agent against Enterovirus A71 (EV-A71)
by: Salima Lalani, et al.
Published: (2021-08-01)

A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71.
by: Wang, X, et al.
Published: (2012)

A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71
by: Wang, X, et al.
Published: (2012)

The Immungenicity and Cross-Neutralizing Activity of Enterovirus 71 Vaccine Candidate Strains
by: Xia Xiao, et al.
Published: (2021-08-01)

Molecular Docking of SP40 Peptide towards Cellular Receptors for Enterovirus 71 (EV-A71)
by: Malihe Masomian, et al.
Published: (2021-10-01)

The expression of recombinant bacille calmette-guerin (rBCG) containing VPI gene of enterovirus 71 (EV71)
by: Wey, Goh Kai
Published: (2008)

Correction: Phenotypic and Genotypic Characteristics of Novel Mouse Cell Line (NIH/3T3)-Adapted Human Enterovirus 71 Strains (EV71:TLLm and EV71:TLLmv)
Published: (2014-01-01)

Partial protection against enterovirus 71 (EV71) infection in a mouse model immunized with recombinant newcastle disease virus capsids displaying the EV71 VP1 fragment.
by: Wei, Choong Ch'ng, et al.
Published: (2011)

Correlates of protection for inactivated enterovirus 71 vaccine: the analysis of immunological surrogate endpoints
by: Wenbo Zhu, et al.
Published: (2017-09-01)

Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China
by: Xiaoli Wang, et al.
Published: (2019-05-01)

Enterovirus 71-Associated Infection in South Vietnam: Vaccination Is a Real Solution
by: Natalia I. Romanenkova, et al.
Published: (2023-05-01)

An infectious clone of enterovirus 71(EV71) that is capable of infecting neonatal immune competent mice without adaptive mutations
by: Huiying Zhang, et al.
Published: (2020-01-01)

Receptors for enterovirus 71
by: Seiya Yamayoshi, et al.
Published: (2014-01-01)

Interaction between PHB2 and Enterovirus A71 VP1 Induces Autophagy and Affects EV-A71 Infection
by: Weitao Su, et al.
Published: (2020-04-01)

Construction Of Recombinant Bcg Expressing The Vp1 Antigen Of Enterovirus 71 For The Development Of A Candidate Vaccine
by: Othman, Nurulhasanah
Published: (2006)

Short-term dynamic changes in neutralizing antibodies against enterovirus 71 after vaccination
by: Shenyu Wang, et al.
Published: (2020-07-01)

Immunogenicity study of dna vaccine and dna vaccine carrier expressing vp1 of enterovirus 71 in the prime boost vaccination strategy
by: Nur Ayuni, Kadir
Published: (2008)

Development of human enterovirus 71 nano calcium phosphate adjuvanted candidate vaccine for parenteral and mucosal delivery
by: Saeed Ahmed, Mohamed Ibrahim
Published: (2015)

Development of live attenuated Enterovirus 71 vaccine strains that confer protection against lethal challenge in mice
by: Yee, Pinn Tsin Isabel, et al.
Published: (2019)

Enterovirus 71 outbreak, Brunei
by: AbuBakar, Sazaly, et al.
Published: (2009)

Outbreaks of enterovirus 71 infection
by: AbuBakar, Sazaly, et al.
Published: (2000)

Enterovirus 71 Outbreak, Brunei
by: Sazaly AbuBakar, et al.
Published: (2009-01-01)

Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy
by: Pei Liu, et al.
Published: (2021-04-01)

A novel mucosal bivalent vaccine of EV-A71/EV-D68 adjuvanted with polysaccharides from Ganoderma lucidum protects mice against EV-A71 and EV-D68 lethal challenge
by: Yu-Li Lin, et al.
Published: (2023-12-01)

Adaptation and Virulence of Enterovirus-A71
by: Kyousuke Kobayashi, et al.
Published: (2021-08-01)

Children with severe enterovirus A71 infection
by: Wenjuan Wu, et al.
Published: (2023-04-01)

Evidence of enterovirus 71 infections in Brazil
by: Edson E. da Silva, et al.
Published: (1990-03-01)

Correction: A Dominant EV71-Specific CD4+ T Cell Epitope Is Highly Conserved among Human Enteroviruses.
by: Ruicheng Wei, et al.
Published: (2014-01-01)

Correction: A Dominant EV71-Specific CD4+ T Cell Epitope Is Highly Conserved among Human Enteroviruses
Published: (2014-01-01)

Safety and immunogenicity of an experimental live combination vaccine against enterovirus 71 and coxsackievirus A16 in rhesus monkeys
by: Ting Yang, et al.
Published: (2020-07-01)

Sentinel Surveillance for Enterovirus 71, Taiwan, 1998
by: Trong-Neng Wu, et al.
Published: (1999-06-01)

Enterovirus 71 in Malaysia: A decade later
by: Chan, Yoke Fun, et al.
Published: (2011)